Predicting the CRISPR Cas9 Market Collapse (2)

By: James V. Kohl | Published on: September 11, 2018

In a matter of days, the focus of personalized medicine has changed to ecological adaptations that eliminate the CRISPR Cas9 technology from any further consideration whatsoever.

The quantized energy-dependent creation of the microRNA-mediated adaptive immune system is nothing new, and no “new forms” have been discovered since the dawn of creation.

See also: Kalevi Kull: Censorship & Royal Society Evo Event

Nobody wants to belong to the party of losers. One of the best strategies in such a case is evidently an interpretation of the change as a gradual accumulation of knowledge while their work has always been at the cutting edge. — Kalevi Kull

Notify of
Inline Feedbacks
View all comments

Want more on the same topic?

Swipe/Drag Left and Right To Browse Related Posts: